Volumizing with a 20-mg/mL smooth, highly cohesive, viscous hyaluronic acid filler and its role in facial rejuvenation therapy.
Source
Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada. drjean@carruthers.net
Abstract
BACKGROUND:
The new 20 mg/mL hyaluronic acid (HA) dermal filler is a smooth, highly cohesive, viscous formulation developed to restore volume in aesthetic facial rejuvenation. OBJECTIVE Evaluate clinical experience with 20 mg/mL HA dermal filler to date and comment on its current and potential uses within the facial rejuvenation treatment paradigm.
METHODS AND MATERIALS:
In this paper, the authors review the unique physical and chemical properties of 20 mg/mL HA dermal filler as well as clinical experience with the product to date.
RESULTS:
Overall, the 20 mg/mL smooth, cohesive, viscous HA filler was especially effective in restoring volume in the malar region and chin. Volume loss resolved significantly in patients in clinical trials(1) and treatment effects were observed to be maintained from six to 18 months.(2) Physicians reported the agent was highly effective as well as easy to inject, sculpt and mold. The treatment was generally well tolerated and no instances of product migration from the injection site have been reported. Patient satisfaction was high, with the vast majority of trial participants acknowledging they would return for additional treatment and recommend the treatment to friends.(1,2)
CONCLUSION:
Initial experience shows the 20 mg/mL smooth, cohesive, viscous HA filler to be a useful addition to the facial rejuvenation armamentarium when used both alone and in combination with BTX-A.
© 2010 by the American Society for Dermatologic Surgery, Inc.
- PMID:
- 20969666
- [PubMed - indexed for MEDLINE]
상기 내용은 abstract입니다. 전체 저널 내용은 저작권 문제 때문에 올리지 못합니다. 더많은 내용을 보시고 싶으신 분은 pubmed.com에서 해당 저널을 구입하셔야 됩니다.
|
